Page last updated: 2024-08-16

opc 12759 and alpha-synuclein

opc 12759 has been researched along with alpha-synuclein in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Krishnamurthy, S; Mishra, A	1

Other Studies

1 other study(ies) available for opc 12759 and alpha-synuclein

Article	Year
Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats. Neurotoxicity research, 2019, Volume: 35, Issue:3 Topics: Administration, Oral; Alanine; alpha-Synuclein; Animals; Antioxidants; Antiparkinson Agents; Apoptosis; Dose-Response Relationship, Drug; Energy Metabolism; Functional Laterality; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Quinolones; Random Allocation; Rats; Substantia Nigra	2019

Article

Year

Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats.

Neurotoxicity research, 2019, Volume: 35, Issue:3

Topics: Administration, Oral; Alanine; alpha-Synuclein; Animals; Antioxidants; Antiparkinson Agents; Apoptosis; Dose-Response Relationship, Drug; Energy Metabolism; Functional Laterality; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Quinolones; Random Allocation; Rats; Substantia Nigra

2019